Literature DB >> 15579759

The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome.

E O Talbott1, J V Zborowski, M Y Boudreaux, K P McHugh-Pemu, K Sutton-Tyrrell, D S Guzick.   

Abstract

Polycystic ovary syndrome (PCOS) is associated with premature carotid atherosclerosis. C-Reactive protein (CRP) has been implicated as a vascular disease risk factor. The objective of this study was to determine whether elevated CRP is associated with increased carotid intima-media wall thickness (IMT) in PCOS women. Forty-seven PCOS patients and 59 similarly aged controls were screened for cardiovascular risk factors and concurrently underwent carotid ultrasonography (1996-1999). The main outcome measure was carotid IMT. CRP was significantly higher in PCOS patients than in controls (3.4 vs. 2.1 mg/dl; P = 0.002). In regression modeling, PCOS associated with IMT independently of CRP and age (P = 0.019). Body mass index reduced the association of PCOS and CRP with IMT and was also associated with IMT (P = 0.029). The CRP-IMT relationship was attenuated when either insulin or visceral fat was included in the PCOS-age-CRP model (P = 0.197 and P = 0.550, respectively). PCOS remained associated with IMT independent of insulin (P = 0.033) or visceral fat (P = 0.040). CRP does not appreciably mediate the effect of PCOS on IMT. Obesity partially explained the influence of PCOS and CRP on IMT. The effect of body mass index on the PCOS-IMT relationship was not completely determined by hyperinsulinemia or visceral fat, and might be mediated by other aspects of PCOS-related adiposity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579759     DOI: 10.1210/jc.2003-032110

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.

Authors:  Carolyn J Alexander; Edward P Tangchitnob; Norman E Lepor
Journal:  Rev Obstet Gynecol       Date:  2009

2.  Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk.

Authors:  E Gourgari; M Lodish; R Shamburek; M Keil; R Wesley; M Walter; M Sampson; S Bernstein; D Khurana; C Lyssikatos; S Ten; A Dobs; A T Remaley; C A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2015-09-15       Impact factor: 5.958

Review 3.  Insulin resistance in PCOS.

Authors:  Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

Review 4.  Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.

Authors:  Héctor F Escobar-Morreale; Manuel Luque-Ramírez; Frank González
Journal:  Fertil Steril       Date:  2010-12-17       Impact factor: 7.329

5.  Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity.

Authors:  Hideo Makimura; Takara Stanley; David Mun; Cindy Chen; Jeffrey Wei; Jean M Connelly; Linda C Hemphill; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

6.  Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.

Authors:  Marco Matteo Ciccone; Stefano Favale; Anish Bhuva; Pietro Scicchitano; Vito Caragnano; Cristina Lavopa; Giovanni De Pergola; Giuseppe Loverro
Journal:  Vasc Health Risk Manag       Date:  2009-06-29

7.  Is there a link between polycystic ovary syndrome and non-thyroidal illness syndrome?

Authors:  Melia Karaköse; Erman Cakal; Oya Topaloğlu; Müyesser Sayki Arslan; Zeynep Giniş; Mustafa Sahin; Tuncay Delibaıı
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-12-01

8.  Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome.

Authors:  Kara S Hughan; Hala Tfayli; Julia G Warren-Ulanch; Emma Barinas-Mitchell; Silva A Arslanian
Journal:  J Pediatr       Date:  2015-11-03       Impact factor: 4.406

9.  Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome.

Authors:  Elif Agacayak; Senem Yaman Tunc; Sibel Sak; Serdar Basaranoglu; Hatice Yüksel; Abdulkadir Turgut; Talip Gul
Journal:  Med Sci Monit       Date:  2015-08-20

10.  Study of early atherosclerotic markers in women with polycystic ovary syndrome.

Authors:  Ritu Karoli; Jalees Fatima; Zeba Siddiqi; Priti Vatsal; Amit R Sultania; Sumit Maini
Journal:  Indian J Endocrinol Metab       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.